Research Article
Paeoniflorin, the Main Active Ingredient of Shuyu Capsule, Inhibits Cav1.2 and Regulates Calmodulin/Calmodulin-Dependent Protein Kinase II Signalling
Figure 4
Whole-cell patch clamp analysis of CHO cells with LTCC constitutive expression. (a) 1.2 current density was recorded and analysed for the following groups: blank control, positive control (1 μM nifedipine treatment), 50 μM paeoniflorin treatment, 100 μM paeoniflorin treatment, and 200 μM paeoniflorin treatment. (b) Inhibition ratios for 1 μM nifedipine treatment, 50 μM paeoniflorin treatment, 100 μM paeoniflorin treatment, and 200 μM paeoniflorin treatment.
(a) |
(b) |